Concepedia

Shubham Pant

SP

Statistics

Publications

128

Citations

8.5K

H-Index

45

Active since

2005

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Sarah Cannon

Tennessee Oncology

Memorial Sloan Kettering Cancer Center

University of Oklahoma Health Sciences Center

Shubham Pant is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, radiation oncology, and oncology.

ORCID

Top concepts

Publications per year

2005–2025

128

Publications

128

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Andrea Wang‐Gillam, Chung‐Pin Li, G. Bodoky et al. · The Lancet · 2015 · 1.2K citations

, , +8

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial

Zev A. Wainberg, Davide Melisi, Teresa Macarulla et al. · The Lancet · 2023 · 374 citations · Full text

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials

Timothy A. Yap, Naval Daver, Mikhila Mahendra et al. · Nature Medicine · 2023 · 335 citations · Full text

, , +8

Metastatic Pancreatic Cancer: ASCO Guideline Update

Davendra Sohal, Erin B. Kennedy, Pelin Cinar et al. · Journal of Clinical Oncology · 2020 · 271 citations

First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors

Gerald S. Falchook, Jeffrey R. Infante, Hendrik‐Tobias Arkenau et al. · EClinicalMedicine · 2021 · 250 citations · Full text

Rows per page

1–5 of 128